Personalized Medical Care & Dedicated International Patient Concierge
Medical Guide
Stem Cell Therapy vs. Platelet-Rich Plasma (PRP): Understanding the Differences
A neutral guide to how stem cell therapy and platelet-rich plasma (PRP) differ, what each is, and their investigational regulatory status in the US.
Schedule a ConsultationMedically reviewed by Dr. Seok Lee, Lead Physician, Pentaheal Medical Group
Two regenerative approaches come up again and again when people research options for degenerative joint problems, sports injuries, and age-related tissue changes: stem cell therapy and platelet-rich plasma, usually shortened to PRP. They are frequently mentioned together and sometimes confused, but they are not the same thing. This article explains, in plain language, what each one is, how they differ conceptually, and what their regulatory status is in the United States. Just as importantly, it is honest about the limits of the evidence. Both approaches are best understood as investigational for these regenerative and degenerative uses, and neither is approved by the U.S. Food and Drug Administration (FDA) for them. The goal here is understanding, not persuasion, and no outcome can be promised.
Why People Consider Regenerative Options
Many people who look into PRP or stem cell therapy are living with degenerative or musculoskeletal conditions. Osteoarthritis is a common example. According to the Mayo Clinic, osteoarthritis develops when the protective cartilage cushioning the ends of bones wears down over time, producing pain, stiffness, and reduced movement, most often in the knees, hips, hands, and spine. Others are dealing with the aftermath of a sports injury. The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) notes that sports injuries such as sprains, strains, and tendon problems are common, that treatment usually starts conservatively with rest and rehabilitation, and that recovery time varies widely.
Because conventional treatments for these conditions often focus on managing symptoms, some patients become interested in approaches described as regenerative, which are framed around supporting the body's own repair processes. PRP and stem cell therapy are the two most talked-about examples. It is worth setting expectations from the start: these are areas of ongoing research, the science is still developing, and being interested in a regenerative option is reasonable, but so is approaching it with careful, well-informed questions.
What Platelet-Rich Plasma (PRP) Is
PRP is an autologous treatment, which simply means it is made from the patient's own body. To prepare it, a clinician draws a sample of your blood, then processes it, typically by spinning it in a centrifuge, to concentrate the platelets. Platelets are cell fragments in blood best known for their role in clotting, but they also contain growth factors that are involved in the body's natural healing and signaling processes. The concentrated platelet portion is then injected into or around the area being treated.
The concept behind PRP is that concentrating these growth factors at a site of injury or degeneration might support the body's healing response. Because the material comes from your own blood, PRP is generally considered to have a favorable safety profile compared with using material from another source, though no injection procedure is risk-free.
Here the evidence picture needs to be stated plainly. PRP is widely used and studied, but for regenerative and degenerative indications the evidence is mixed and still developing, and it is not FDA-approved for these uses. In other words, while PRP is popular and derived from your own blood, that does not mean its effectiveness for a given condition has been established. Results vary considerably from study to study and from person to person, and it should be understood as investigational for these purposes.
What Stem Cell Therapy Is
Stem cell therapy is a different category. Stem cells are cells with the potential to develop into other cell types and to participate in the body's repair and maintenance processes, which is why they are an active focus of scientific study. In regenerative medicine, one type often discussed is the mesenchymal stem cell, or MSC. The general idea is that stem cells are being studied for their potential to influence tissue repair, though what actually happens after they are administered is still being researched.
A meaningful practical difference from PRP concerns the source of the cells. With PRP, the source is clear: your own blood. With stem cell therapy, the source can vary, and it is important to be transparent that Pentaheal's public materials do not disclose the specific stem cell source used. If the source matters to you, and it reasonably might, that is an appropriate question to raise directly during a consultation.
As with PRP, the regulatory status is central. Stem cell therapies are not approved by the U.S. FDA for safety or effectiveness in degenerative, orthopedic, anti-aging, or systemic conditions. The FDA has issued a consumer alert on regenerative medicine products, including stem cells and exosomes, warning that many marketed products have not been reviewed or approved by the agency, that some are being sold with unproven claims, and that they can carry serious safety risks. The FDA has separately warned consumers about unapproved stem cell therapies. Being available at a clinic is not evidence that a treatment works.
Pentaheal Medical Group, a functional and regenerative medicine clinic in Seocho District, Seoul, describes its non-surgical stem cell and regenerative care in exploratory terms, as care studied for its potential to support the body's natural repair processes. The clinic operates under South Korea's advanced regenerative medicine framework and is a Ministry of Health and Welfare–registered institution for foreign patients. These are Korean regulatory designations and are not the same as U.S. FDA approval, and they do not by themselves prove efficacy. You can review how the clinic presents these services on its main website.
Key Differences at a Glance
Comparing PRP and stem cell therapy side by side clarifies where they genuinely differ and where they are similar.
What the material is. PRP is concentrated platelets and their growth factors from your own blood. Stem cell therapy uses stem cells, which are a different kind of biological material with the potential to develop into other cell types.
Source. PRP is autologous by definition, drawn from the patient. For stem cell therapy, the source can vary, and Pentaheal does not publicly disclose the specific source it uses, which is a fair thing to ask about.
Preparation. PRP preparation is relatively straightforward: a blood draw followed by concentration, often in a centrifuge, on the same visit. Stem cell approaches involve more complex handling that depends on the source and processing method.
Evidence. For these regenerative and degenerative uses, PRP has a mixed and still-developing evidence base, while stem cell therapy remains investigational and under study. Neither has established, FDA-approved effectiveness for these indications.
Regulatory status. This is the most important shared point: both PRP and stem cell therapy are not FDA-approved for regenerative and degenerative uses. The FDA has specifically cautioned consumers about unproven regenerative and stem cell products.
The practical message is that these are two distinct approaches with different biology and different logistics, but they land in a similar regulatory place for these uses. That shared status is a key reason both deserve careful, physician-guided consideration rather than assumptions based on popularity alone.
Making an Informed, Physician-Led Decision
Because both approaches are investigational for these uses, the decision to pursue either one should be made with a qualified physician who has evaluated you, and after an honest conversation about uncertainty. Pentaheal describes a diagnostics-first model with three broad steps: a functional health evaluation, precision diagnostic testing, and then a personalized treatment plan. The clinic states that Dr. Seok Lee is personally involved through a 1:1 physician care model, and that virtual pre-consultation is available for international patients before any travel is planned.
Several considerations usually belong in that conversation. What is your exact diagnosis, and at what stage is it? What have you already tried, and how did you respond? Are there contraindications in your history? Pentaheal lists documented contraindications for regenerative care, including active cancer or a cancer history pending evaluation, severe active infection, autoimmune conditions during an acute flare, pregnancy, severe thrombocytopenia, and uncontrolled medical conditions. And crucially, what does the current evidence actually support, and what does it not? Asking a clinic to be candid about uncertainty, including the FDA's cautions, is a sign of a well-informed patient.
Cost and candidacy are confirmed at consultation rather than stated in advance. Pentaheal is a reservation-based clinic that requires a deposit to confirm a booking, with the balance due before the program begins; those details are reviewed during the consultation process. If you want to discuss how PRP and stem cell approaches are considered for your situation, you can reach the clinic through its contact page. What no article can do is tell you which, if either, is appropriate for you. That determination rests on an individualized medical evaluation and a clear-eyed understanding of the evidence.
Questions Worth Asking at a Consultation
Because both PRP and stem cell therapy are investigational for these uses, the quality of the conversation you have with a clinic matters a great deal. A few questions can help you make a well-informed decision rather than one based on marketing language. Consider asking what the specific goal of the proposed treatment is, whether it is aimed at symptom relief or framed as regenerative, and what realistic timeline is being described. Ask what the current evidence actually supports for your particular condition, and, just as importantly, what it does not support. A clinic that is comfortable discussing the limits of the evidence and the FDA's cautions is giving you the information you need.
It is also reasonable to ask about the material itself. For PRP, that means understanding how your blood will be drawn and processed. For stem cell therapy, it means asking about the source, since Pentaheal's public materials do not disclose the specific stem cell source used, and the source can be relevant to your questions. You can ask about the procedure, what is known about potential risks, how progress will be monitored, and what follow-up looks like. Pentaheal describes recovery as gradual, with light activity soon after and any biological improvement described in exploratory terms over weeks to months.
Finally, ask about candidacy and contraindications. A responsible clinic will screen for factors that make regenerative care inappropriate, and it will confirm candidacy through evaluation rather than assuming it. The clinic states that Dr. Seok Lee is personally involved in this process, that virtual pre-consultation is available for international patients, and that cost and candidacy are confirmed at consultation. These questions are not a sign of distrust; they are how thoughtful patients and thoughtful clinicians work together toward a sound decision.
Bottom Line
- PRP and stem cell therapy are distinct regenerative approaches; PRP is autologous, made from the patient's own blood and its growth factors, while stem cell therapy uses stem cells that can come from various sources.
- Pentaheal's public materials do not disclose the specific stem cell source it uses, which is a reasonable question to raise at consultation.
- Both approaches are investigational for regenerative and degenerative uses and are not FDA-approved for them; PRP's evidence is mixed and still developing, and stem cell therapy remains under study.
- The FDA has warned consumers about unproven stem cell and regenerative products, including a consumer alert covering stem cells and exosomes; results vary and no cure or guaranteed outcome can be promised.
- Any decision between or about these options should be made with a qualified physician through individualized evaluation, with cost and candidacy confirmed at consultation.
Frequently Asked Questions
**What is the main difference between PRP and stem cell therapy?**PRP uses concentrated platelets and growth factors taken from your own blood, so it is autologous by definition. Stem cell therapy uses stem cells, a different type of biological material with the potential to develop into other cell types, and the source can vary. They differ in the material used, how it is prepared, and their source.
**Is PRP safer than stem cell therapy because it comes from my own body?**PRP being autologous means the material is your own, which many consider a favorable feature, but no injection is risk-free, and being autologous does not make a treatment effective. Both PRP and stem cell therapy are investigational for regenerative and degenerative uses, so safety and appropriateness should be assessed individually by a physician.
**Are either PRP or stem cell therapy approved by the FDA for joint or degenerative conditions?**No. Neither PRP nor stem cell therapy is FDA-approved for these regenerative and degenerative uses. PRP's evidence for such uses is mixed and still developing, and stem cell therapy remains investigational. The FDA has issued warnings and a consumer alert about unproven stem cell and regenerative products.
**What stem cell source does Pentaheal use?**Pentaheal's public materials do not disclose the specific stem cell source used. Because the source can be relevant to your questions and considerations, it is appropriate to ask about it directly during a consultation, where the clinic can respond to your individual situation.
**How should I decide whether PRP or stem cell therapy is right for me?**Through an individualized evaluation with a qualified physician and an honest discussion of the evidence and its limits. Pentaheal describes a diagnostics-first process, a functional health evaluation, precision testing, and then a personalized plan, with cost and candidacy confirmed at consultation. No article can replace that assessment, and results vary from person to person.
This article is for general informational purposes and does not constitute individualized medical advice. Consult a qualified physician about your specific condition.
More Articles
Continue reading our clinical guides.
Korean Board-Certified Care: Safety in Functional Medicine Standards
Chronic spine, joint, and cancer-related pain affects millions of families across South Korea.
Learn More
Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide
Discover Seoul Korea's top functional medicine clinic for Americans. PENTAHEAL's complete guide to autoimmune, chronic disease and longevity programs in 2026.
Learn More
Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol
Seeking metabolic syndrome treatment Seoul Korea? PENTAHEAL Medical Group offers a 1:1 metabolic reset program led by Dr. Seok Lee. Book your consult today.
Learn More